Back to news



Antibodies in serum of convalescent patients following mild COVID-19 do not always prevent virus-receptor binding

Gattinger P, Borochova K, Dorofeeva Y, Henning R, Kiss R, Kratzer B, Mühl B, Perkmann T, Trapin D, Trella M, Ettel P, Tulaeva I, Pickl WF, Valenta R. Allergy. 2021 Mar;76(3):878-883.

doi: 10.1111/all.14523. 

After the appearance of first cases in Wuhan, China in December 2019, the novel human coronavirus disease, COVID-19, has become the first coronavirus pandemic in history.1 On 16 July 2020, more than 13.5 million patients worldwide have been infected with the novel coronavirus, SARS-CoV-2, and more than 584.000 global deaths related to COVID-19 have been reported (see: The Center for Systems Science and Engineering (CSSE) at Johns Hopkins University, Baltimore


Get news from us

You've been subscribed